{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:19:49Z","timestamp":1767676789997},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30972583","81071338"],"award-info":[{"award-number":["30972583","81071338"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.virusres.2013.08.003","type":"journal-article","created":{"date-parts":[[2013,8,19]],"date-time":"2013-08-19T15:45:49Z","timestamp":1376927149000},"page":"156-162","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dynamics of hepatitis B virus resistance substitutions correlates with virological response in lamivudine-refractory patients with entecavir rescue monotherapy"],"prefix":"10.1016","volume":"177","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2013.08.003_bib0005","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1471-2334-11-178","article-title":"Unsuccessful therapy with adefovir and entecavir-tenofovir in a patient with chronic hepatitis B infection with previous resistance to lamivudine: a fourteen-year evolution of hepatitis B virus mutations","volume":"11","author":"Cassino","year":"2011","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.virusres.2013.08.003_bib0010","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/hep.21422","article-title":"Entecavir resistance is rare in nucleoside na\u00efve patients with hepatitis B","volume":"44","author":"Colonno","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2013.08.003_bib0015","doi-asserted-by":"crossref","DOI":"10.1007\/s11262-013-0915-1","article-title":"Dynamics of lamivudine-resistant hepatitis B virus strains in patients with entecavir rescue therapy","author":"Deng","year":"2013","journal-title":"Virus Genes"},{"key":"10.1016\/j.virusres.2013.08.003_bib0020","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.molcel.2006.04.025","article-title":"Native hepatitis B virions and capsids visualized by electron cryomicroscopy","volume":"22","author":"Dryden","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.virusres.2013.08.003_bib0025","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1128\/AAC.47.8.2624-2635.2003","article-title":"Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection","volume":"47","author":"Foster","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2013.08.003_bib0030","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1002\/hep.22900","article-title":"Antiviral resistance and hepatitis B therapy","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2013.08.003_bib0035","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2169\/internalmedicine.51.7329","article-title":"Rescue therapy for lamivudine-resistant chronic hepatitis B: adefovir monotherapy, adefovir plus lamivudine or entecavir combination therapy","volume":"51","author":"Ha","year":"2012","journal-title":"Intern. Med."},{"key":"10.1016\/j.virusres.2013.08.003_bib0040","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/jmv.21206","article-title":"Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy","volume":"80","author":"Ijaz","year":"2008","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virusres.2013.08.003_bib0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jmv.23392","article-title":"Do different lamivudine-resistant hepatitis B genotypes carry the same risk of entecavir resistance?","volume":"85","author":"Lee","year":"2013","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virusres.2013.08.003_bib0050","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/JVI.80.2.643-653.2006","article-title":"Dynamics of hepatitis B virus resistance to lamivudine","volume":"80","author":"Pallier","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2013.08.003_bib0055","first-page":"835","article-title":"Frequency and mutation patterns of resistance in patients with chronic hepatitis B infection treated with nucleos(t)ide analogs in add-on and switch strategies","volume":"11","author":"Sayan","year":"2011","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.virusres.2013.08.003_bib0060","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/1743-422X-8-393","article-title":"Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis","volume":"8","author":"Sheng","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.virusres.2013.08.003_bib0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/hep.22323","article-title":"Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks","volume":"48","author":"Sherman","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2013.08.003_bib0070","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1053\/j.gastro.2006.04.007","article-title":"Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B","volume":"130","author":"Sherman","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virusres.2013.08.003_bib0075","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/j.1440-1746.2008.05455.x","article-title":"Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: randomized controlled trial in Japanese patients","volume":"23","author":"Suzuki","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.virusres.2013.08.003_bib0080","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/AAC.48.9.3498-3507.2004","article-title":"Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine","volume":"48","author":"Tenney","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2013.08.003_bib0085","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1128\/AAC.00833-06","article-title":"Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present","volume":"51","author":"Tenney","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2013.08.003_bib0090","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jhep.2003.09.022","article-title":"Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient","volume":"39","author":"Villeneuve","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virusres.2013.08.003_bib0095","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/hep.21290","article-title":"Evolution of multi-drug resistant hepatitis B virus during sequential therapy","volume":"44","author":"Yim","year":"2006","journal-title":"Hepatology"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170213002669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170213002669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T21:28:46Z","timestamp":1539466126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170213002669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0168170213002669"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2013.08.003","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamics of hepatitis B virus resistance substitutions correlates with virological response in lamivudine-refractory patients with entecavir rescue monotherapy","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2013.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}